MindBio Therapeutics (XCNQ:MBIO) Cash Flow for Dividends : C$0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Cash Flow for Dividends?

MindBio Therapeutics's cash flow for dividends for the three months ended in Mar. 2024 was C$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

MindBio Therapeutics's annual payment of dividends increased from Jun. 2021 (C$0.00 Mil) to Jun. 2022 (C$-0.71 Mil) but then declined from Jun. 2022 (C$-0.71 Mil) to Jun. 2023 (C$0.00 Mil).

MindBio Therapeutics Cash Flow for Dividends Historical Data

The historical data trend for MindBio Therapeutics's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Cash Flow for Dividends Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Cash Flow for Dividends

-0.71

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial					-	-	-	-	-

MindBio Therapeutics Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

MindBio Therapeutics Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.